ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
10.10
0.00
(0.00%)
Cerrado 05 Febrero 10:30AM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
10.10
Postura de Compra
10.00
Postura de Venta
10.10
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
9.94 Rango de 52 semanas 11.60
Capitalización de Mercado [m]
Precio Anterior
10.10
Precio de Apertura
-
Hora
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
49,359
Acciones en circulación
69,151,168
Rendimiento del Dividendo
7.03%
Ratio Precio/Utilidad
31.46
Beneficio por acción (BPA)
0.27
turnover
62.21M
Beneficio neto
18.42M

Acerca de Partners Group Private Equity Limited

Sector
Unit Inv Tr, Closed-end Mgmt
Industria
Unit Inv Tr, Closed-end Mgmt
Sede
Guernsey, Gbr
Fundado
-
Partners Group Private Equity Limited is listed in the Unit Inv Tr, Closed-end Mgmt sector of the London Stock Exchange with ticker PEY. The last closing price for Partners Group Private E... was 10.10 €. Over the last year, Partners Group Private E... shares have traded in a share price range of 9.94 € to 11.60 €.

Partners Group Private E... currently has 69,151,168 shares in issue. The market capitalisation of Partners Group Private E... is 698.43 € million. Partners Group Private E... has a price to earnings ratio (PE ratio) of 31.46.

PEY Últimas noticias

Partners Group Private Equity Ltd NAV increases by 1.2% in November

Partners Group Private Equity Ltd 08 January 2025   (LSE: PEYS/PEY)   Partners Group Private Equity Limited   NAV increases by 1.2% in November     ·    NAV increased by 1.2% to EUR 14.40 per...

Partners Group Private Equity Ltd Vishal Mega Mart lists on Stock Exchanges in India

Partners Group Private Equity Ltd 20 December 2024   (LSE: PEYS/PEY)   Partners Group Private Equity Limited   Investee company Vishal Mega Mart prices IPO and lists on National Stock Exchange...

Partners Group Private Equity Ltd Holding(s) in Company

Partners Group Private Equity Ltd 12 December 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GG00B28C2R28 Issuer Name Partners Group Private Equity...

Partners Group Private Equity Ltd Holding(s) in Company

Partners Group Private Equity Ltd 12 December 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GG00B28C2R28 Issuer Name Partners Group Private Equity...

Partners Group Private Equity Ltd NAV increases by 2.4% in October

Partners Group Private Equity Ltd 04 December 2024   (LSE: PEYS/PEY)   Partners Group Private Equity Limited   NAV increases by 2.4% in October     ·    NAV increased by 2.4% to EUR 14.58 per...

Partners Group Private Equity Ltd Results presentation webcast details

Partners Group Private Equity Ltd 21 November 2024   (LSE: PEYS/PEY) Partners Group Private Equity Limited   Results presentation webcast details   PGPE Ltd will hold an investor update today...

Partners Group Private Equity Ltd Save the date for Q3 2024 results announcement

Partners Group Private Equity Ltd 05 November 2024   (LSE: PEYS/PEY) Partners Group Private Equity Limited   Save the date for Q3 2024 results announcement   PGPE Ltd will hold an investor...

Partners Group Private Equity Ltd NAV increases by 0.5% in September

Partners Group Private Equity Ltd 04 November 2024   (LSE: PEYS/PEY)   Partners Group Private Equity Limited   NAV increases by 0.5% in September     ·    NAV increased by 0.5% to EUR 14.24...

DIRECTOR DEALINGS: Morgan Sindall CEO sells GBP1.1 million in shares

The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and ...

Partners Group Private Equity Ltd Director/PDMR Shareholding

Partners Group Private Equity Ltd 28 October 2024   NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.1-0.98039215686310.210.3106653710.13203962DE
4-0.5-4.7169811320810.610.6105694010.22243943DE
12-0.5-4.7169811320810.611104935910.46120633DE
26-0.6-5.6074766355110.711.459.944652510.49459999DE
52-0.25-2.415458937210.3511.69.944939310.72902047DE
156-3.15-23.773584905713.2513.47.87239410.09347859DE
260-1.05-9.4170403587411.1514.856.646896610.34326434DE

PEY - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Partners Group Private E...?
El precio actual de las acciones de Partners Group Private E... es 10.10 €
¿Cuántas acciones de Partners Group Private E... están en circulación?
Partners Group Private E... tiene 69,151,168 acciones en circulación
¿Cuál es la capitalización de mercado de Partners Group Private E...?
La capitalización de mercado de Partners Group Private E... es EUR 698.43M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Partners Group Private E...?
Partners Group Private E... ha negociado en un rango de 9.94 € a 11.60 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Partners Group Private E...?
El ratio precio/beneficio de Partners Group Private E... es 31.46
¿Cuál es el ratio de efectivo a ventas de Partners Group Private E...?
El ratio de efectivo a ventas de Partners Group Private E... es 9.32
¿Cuál es la moneda de reporte de Partners Group Private E...?
Partners Group Private E... presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Partners Group Private E...?
El último ingresos anual de Partners Group Private E... es EUR 62.21M
¿Cuál es el último beneficio anual de Partners Group Private E...?
El último beneficio anual de Partners Group Private E... es EUR 18.42M
¿Cuál es la dirección registrada de Partners Group Private E...?
La dirección registrada de Partners Group Private E... es TUDOR HOUSE, LE BORDAGE, ST PETER PORT, GUERNSEY, GY1 6BD
¿Cuál es la dirección del sitio web de Partners Group Private E...?
La dirección del sitio web de Partners Group Private E... es www.princess-privateequity.net
¿En qué sector industrial opera Partners Group Private E...?
Partners Group Private E... opera en el sector UNIT INV TR, CLOSED-END MGMT

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
0A2IH World Group Ltd
US$ 0.00
(0.00%)
0
0A2DCrh Plc
US$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
US$ 69.50
(0.00%)
1.71k
0A2IH World Group Ltd
US$ 0.00
(0.00%)
0
0A2DCrh Plc
US$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
US$ 69.50
(0.00%)
1.71k
STXShield Therapeutics Plc
2.85p
(0.00%)
150k
0RIHAlphabet Inc
US$ 205.30
(0.00%)
11.71k
0HD6Alphabet Inc
US$ 207.20
(0.00%)
8.07k
0HCIAlibaba Group Holding Ltd
US$ 103.70
(0.00%)
7.86k
0R24Intel Corp
US$ 19.575
(0.00%)
6.79k
zino zino 5 minutos hace
if we get the right Quant Merger this will explode and also
could turn turn into be a potential Nasdaq uplisting
Just look at RgtI and its run and the money it easily raised
GCAN
pgsd pgsd 9 minutos hace
Typical for anything related to DCVax lol

It is included in the list of Proposed 24-25 HC Drugs:

In the alphabetic order from the list it is listed as 'Brain cancer vaccine' which is then crossed out and Murcidencel is added...

https://investorshub.advfn
NWBO
muee88 muee88 10 minutos hace
Also, the Proposed 24-25 HC drug list is alphabetical, but Murcidencel is listed under the Bs because “Brain Cancer Vaccine” is crossed out and replaced with Murcidencel.
NWBO
TurboMountain96 TurboMountain96 10 minutos hace
Frankly, we are the original MEGA, Make Elite Great Again. We had that slogan long before Trump entered politics or plagiarized from Ronald Reagan, who originally started Make America Great Again. So to that end, maybe to support the stockholders, our MEGA, we’re going to build a wall of needle move
ELTP
RichieBoy RichieBoy 11 minutos hace
Only stating the patently obvious here...

When AFFU's dilution stops, the share price contraction stops. Just that simple. I get a strong sense the company is intentionally stalling for that reason. Mike Balkin and AFFU's other board member(s?) don't want to waste material event comp
AFFU
OnTrack444 OnTrack444 12 minutos hace

Is this your newest made pump account with a 122 followers on X?   😂   Total comedy 🎭 

How much do they pay you to pump bloated pigs because you cer
HMBL
muee88 muee88 15 minutos hace
Unfortunately, I don’t know how to upload a screenshot to this antiquated website —it shouldn’t be this difficult. I can assure you I’m not lying. Also, an email can be faked too so I’m not really sure what a screenshot would tell you.

However, here’s essentially the full text of the
NWBO
123tom 123tom 18 minutos hace
Steve, what you're saying about AVXL price movement not holding the support levels you'd expect... that's something I've watched AVXL do for 14 years. It's what I call the "bleeding down game". I always expect to see lower lows than we ought to see. Even in bullish upwave patterns.... the seller
AVXL
muee88 muee88 21 minutos hace
You need to click the tap entitled “Proposed 24-25 HC drugs.” On my phone, the tab I’m talking about is shown across the top of the website.
NWBO
skitahoe skitahoe 23 minutos hace
When I use your link I get a list of their hospitals, not drugs, am I doing something wrong, or is there a problem with the link.

Thanks,

Gary
NWBO
roadkilll roadkilll 28 minutos hace
Why central banks’ hunger for gold shows ‘no sign of being quelled’ this year
Published: Feb. 5, 2025

Central banks, as well as exchange-traded-fund investors, are likely to drive gold demand this year, with economic uncertainty supporting gold’s role as a risk hedge, the Worl
IAG
demonsmith demonsmith 28 minutos hace
There working on it noting going to happen intell after shareholder metting
TWOH
roadkilll roadkilll 32 minutos hace
Tesla hasn't paid taxes in 3 years
200 P/E
5.5 PEG
$7500 taxpayer from taxpayers to anyone buying a new Tesla
$4000 taxpayer funded payment anyone buying a used Tesla to keep the flow going
30% taxpayer funding to anyone that instals a home battery unit ($3000 if y
TSLA
bluebird50 bluebird50 33 minutos hace
I had a 50 share marker on this and sold it first thing Monday morning.... 

Not feeling good here.... 
pharmas have huge upswings with steady declines!!!  

Time it ladies and gentlemen! 
TNXP
Seminole Red Seminole Red 33 minutos hace
LOLOL
DJPele DJPele 34 minutos hace
Muee, apologies for being persistent, but can you provide a screenshot of the email from the MHRA?
NWBO
muee88 muee88 42 minutos hace
I asked ChatGPT what it meant:

Me: Does Murcidencel being on this list imply that this drug is going to be approved for a marketing authorization?

ChatGPT:

No, the inclusion of Mircidencel on the NHS Proposed 24-25 High-Cost Drugs List does not necessaril
NWBO
muee88 muee88 56 minutos hace
What does Murcidencel being included on this list of “High cost drugs - proposed list for 2024/25” mean?

https://www.england.nhs.uk/wp-content/uploads/2023/12/23-25NHSPS-amendment-consultation-annex.xlsx
NWBO
Werbe Werbe 1 hora hace
Let's get a pr about future intentions, how we make this a $50 m cap company.  I think we can achieve that at least.
ATWT
Seminole Red Seminole Red 1 hora hace
100 feet in difference is only 33 yards, thats pretty close for two vehicles in the air
DocLee DocLee 1 hora hace
HI, DH. Sorry, I don't know whether anybody has contacted either NWBO or the MHRA but you could do it yourself. That would be a much easier option than trawling through tens (or even hundreds) of thousands of messages on this board that have been posted since the MHRA started its assessments. Bes
NWBO
chereb19 chereb19 1 hora hace
The primary objective of this phase I trial is to assess the safety and feasibility of the treatment.
Notably, one patient experienced an exceptional 80% reduction in tumor size during this trial so far. Such a significant response is uncommon in phase I trials, which are primarily designed t
RDGL
trader53 trader53 1 hora hace
DPLS 0.00055 - ALERTING STRONG BUY!


DPLS - Company Update with CEO 2/13/2025
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175756306

DPLS 0.0006 - ALERTING STRONG BUY!
https://investorshub.advfn.com/boards/read_msg.aspx?mess
DPLS MFI

Su Consulta Reciente

Delayed Upgrade Clock